{"id":"W1983840349","doi":"10.1016/j.cgh.2008.02.056","title":"Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients","year":2008,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; London Health Sciences Centre; University of Manitoba; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Adverse effect; Ribavirin; Discontinuation; Internal medicine; Gastroenterology; Hepatitis C virus; Interferon alfa; Insulin resistance; Clinical endpoint; Hepatitis C; Alpha interferon; Randomized controlled trial; Surgery; Immunology; Insulin; Virus; Interferon","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104734,0.0004015674,0.001043847,0.0002720674,0.0003400632,0.000446689,0.0002266547,0.0007089029,0.0009795242],"category_scores_gemma":[0.002117229,0.0002148804,0.0007877763,0.0002655099,0.000388828,0.0005166038,0.0001089924,0.001188104,0.0002454032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000451384,"about_ca_system_score_gemma":0.0003593123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009001164,"about_ca_topic_score_gemma":0.000677355,"domain_scores_codex":[0.9995793,0.0002126284,0.00004140318,0.00005221503,0.00005094592,0.00006351602],"domain_scores_gemma":[0.999157,0.0002846667,0.0002331065,0.00009477236,0.00006340279,0.0001671683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6693209,0.006309209,0.1240849,0.0003619018,0.001145079,0.0007589306,0.0004590745,0.001319785,0.03906929,0.0001346054,0.0008476304,0.1561888],"study_design_scores_gemma":[0.07925966,0.3496741,0.5382611,0.0001405569,0.001939096,0.003242472,0.0004474136,0.003724683,0.01946048,0.0004554449,0.00329864,0.00009639841],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980683,0.001295039,0.00005129785,0.00007261362,0.0000170673,0.0000173132,0.00009736637,0.000009059317,0.0003720721],"genre_scores_gemma":[0.9992674,0.0002128643,0.00005425683,0.00010114,0.00003598896,0.00001370242,0.0001204178,0.000002907325,0.0001914626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00104734,"threshold_uncertainty_score":0.00553894,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0469804487129622,"score_gpt":0.3377987671638918,"score_spread":0.2908183184509296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}